ArticleCommunications biology2019
Insights into the κ/ι-carrageenan metabolism pathway of some marine
Article in Communications biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed.
- Application of Post-Glycosylation Modifying Enzymes for Mass Spectrometry Imaging of ModifiedJournal of the American Society for Mass Spectrometry · 2026Article
- Distribution of microbial carrageenan foraging pathways reveals a widespread latent trait within the ruminant intestinal microbiome.Nature communications · 2026Article
- Identification and Characterization of a New Thermophilic κ-Carrageenan Sulfatase.Journal of agricultural and food chemistry · 2025Article
- Whole genome sequencing of a novel carrageenan-degrading bacteriumFrontiers in microbiology · 2025Article
- Polysaccharide sulfotransferases: the identification of putative sequences and respective functional characterisation.Essays in biochemistry · 2024Review
- ι-Carrageenan catabolism is initiated by key sulfatases in the marine bacteriumApplied and environmental microbiology · 2024Article
- The structure of a pectin-active family 1 polysaccharide lyase from the marine bacterium Pseudoalteromonas fuliginea.Acta crystallographica. Section F, Structural biology communications · 2024Article
- Biocatalytic Conversion of Carrageenans for the Production of 3,6-Anhydro-D-galactose.Journal of agricultural and food chemistry · 2024Article
- Article
- Herbivorous Fish Microbiome Adaptations to Sulfated Dietary Polysaccharides.Applied and environmental microbiology · 2023Article
- Agarolytic Pathway in the Newly Isolated Aquimarina sp. Bacterial Strain ERC-38 and Characterization of a Putative β-agarase.Marine biotechnology (New York, N.Y.) · 2023Article
- Computational Insight into Intraspecies Distinctions inInternational journal of molecular sciences · 2023Article
- SulfAtlas, the sulfatase database: state of the art and new developments.Nucleic acids research · 2023Article
- Separation and Visualization of Glycans by Fluorophore-Assisted Carbohydrate Electrophoresis.Methods in molecular biology (Clifton, N.J.) · 2023Article
- A Novel Carrageenan Metabolic Pathway in Flavobacterium algicola.Applied and environmental microbiology · 2022Article
- Article
- Sulfated glycan recognition by carbohydrate sulfatases of the human gut microbiota.Nature chemical biology · 2022Article
- Molecular Relationships in Biofilm Formation and the Biosynthesis of Exoproducts in Pseudoalteromonas spp.Marine biotechnology (New York, N.Y.) · 2022Review
- Metabolism of a hybrid algal galactan by members of the human gut microbiome.Nature chemical biology · 2022Article
- Structural insights into choline-O-sulfatase reveal the molecular determinants for ligand binding.Acta crystallographica. Section D, Structural biology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.